Hester Biosciences has informed that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Company has scheduled investor interaction through a teleconference call on Wednesday, 17 May 2023 at 2:00 pm (IST), post the announcement of unaudited financial results for the quarter and year ended 31 March 2023. Details for joining the call are attached.